Randomized phase II study comparing Gemcitabine/TS-1 combination chemoradiotherapy with Gemcitabine/TS-1 combination chemotherapy for unresectable locally advanced pancreatic cancer
Phase of Trial: Phase II
Latest Information Update: 24 Nov 2017
At a glance
- Drugs Gimeracil/oteracil/tegafur (Primary) ; Gemcitabine
- Indications Pancreatic cancer
- Focus Therapeutic Use
- 21 Apr 2015 Planned End Date changed from 31 dec 2014 to 1 Sep 2015 as reported by ClinicalTrials.gov record.
- 08 Jun 2014 Planned End Date changed from 15 Dec 2014 to 31 May 2014 as reported by University Hospital Medical Information Network - Japan record.
- 15 Jan 2013 Status changed from recruiting to active, no longer recruiting as reported by University Hospital Medical Information Network - Japan record.